SEC 13F Intelligence

Avidity Partners Management LP / NMRA

Avidity Partners Management LP’s Neumora Therapeutics Inc. Position

Does Avidity Partners Management LP own Neumora Therapeutics Inc. (NMRA)? Not currently — the last reported position was 1.80M shares worth $24M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$24M
Q3 2024
Shares
1.80M
% of Portfolio
+1.21%
Quarters Held
5
position exited

Position History NMRA

Reported value by quarter
Q3 ’23: $25MQ3 ’23Q4 ’23: $34MQ4 ’23Q1 ’24: $25MQ1 ’24Q2 ’24: $18MQ2 ’24Q3 ’24: $24MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.80M$24M+1.21%
Q2 20241.80M$18M+0.75%
Q1 20241.80M$25M+0.80%
Q4 20231.99M$34M+1.24%
Q3 20231.80M$25M+1.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Avidity Partners Management LP’s full portfolio or all institutional holders of NMRA.